Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001493152-17-007777

Director acquired 1,706,978 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schinazi Raymond F Director 2017-07-11 Option exercise +1,706,978 $0.05 $80,228 277,227,831 D
Derivatives
Schinazi Raymond F Director 2017-07-11 Option exercise · Stock Options (Right to Buy) −1,706,978 0 D
Loading xslF345X03/form4.xml…